Early clinical trial results suggest that a groundbreaking new antibiotic drug could be a “massive game changer” for some patients suffering from chronic lower back pain.

A study published in the journal Cell Host & Microbe by Brazilian and American researchers suggests that a diet rich in ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

Data from a meta-analysis of 8 observational studies accounting for more than 26 million people across the globe were ...

Sickle Cell Disease is a genetic blood disorder that affects hemoglobin, causing red blood cells to become rigid and ...

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common but poorly understood condition. Previously known as 'non-bacterial ... old assumption that infection is the cause of ...

These infections mostly happen when the bacteria—often picked up in bodies ... Gregory also says that reducing the incidence of chronic conditions like obesity and diabetes, and treating skin ...

The company is dedicated to educating patients, providers, and others on new findings in chronic hepatitis B virus (HBV) infection. Chronic HBV infection is the most common viral infection in ...